Steven G. Potkin, M.D.
Scientific Council Member Emeritus (Joined 2008)
2013 Distinguished Investigator Grant
Steven G. Potkin, M.D.
Professor, Robert R. Sprague Chair in Brain Imaging
Department of Psychiatry and Human Behavior
Dr. Potkin’s career has been devoted to understanding the causes of, and development of new treatments for schizophrenia, affective disorder, Alzheimer’s disease and other neuropsychiatric diseases. He directs two interdisciplinary research consortia as well as a large clinical trials program. The Biomedical Imaging Research Network is a national consortium of computer scientists, physicists, cognitive scientists and physicians developing tools and the associated infrastructure needed for multi-site neuroimaging studies. He also directs the Transdisciplinary Imaging Genetics Center that develops new methods for combining imaging and genetic data to leverage the power of these disciplines as a gene discovery tool for neuropsychiatric illness.
Dr. Potkin received his M.D. from Washington University in St. Louis and completed his residency in psychiatry at Duke University. Dr. Potkin spent nine years at the NIMH as a clinical research psychiatrist prior to joining the University of California, Irvine.
Learn More About the Foundation
The Brain & Behavior Research Foundation is a global nonprofit organization focused on improving the understanding, prevention and treatment of psychiatric and mental illnesses.
Beginning in 1987, the Brain & Behavior Research Foundation was providing seed money to neuroscientists to invest in “out of the box” research that the government and other sources were unwilling to fund. Today, Brain & Behavior Research Foundation is still the leading, private philanthropy in the world in this space.
Meet the people who make up the Brain & Behavior Research Foundation. Our staff of experts, passionate Board of Directors, and Scientific Council which includes Nobel prize winners and chairs of psychiatric departments around the world.
We take our responsibility to our donors seriously and believe that our financial operations must be transparent. We're proud to say that 100% of your contribution for research is invested directly in research grants.